Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
60.6 USD | +1.80% | +4.68% | -27.42% |
May. 17 | Cytokinetics, Incorporated Announces Resignation of Sandford D. Smith as Board of Directors | CI |
May. 15 | Transcript : Cytokinetics, Incorporated - Shareholder/Analyst Call |
Evolution of the average Target Price on Cytokinetics, Incorporated
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Cytokinetics, Incorporated
Oppenheimer | |
Mizuho Securities | |
UBS | |
B. Riley | |
Truist Securities | |
Needham & Co. | |
HC Wainwright | |
Cantor Fitzgerald | |
Goldman Sachs | |
SVB Securities LLC | |
JPMorgan Chase | |
BofA Securities | |
JMP Securities | |
Raymond James | |
Morgan Stanley | |
Piper Sandler | |
Jefferies & Co. | |
Barclays | |
Wolfe Research |
EPS Revisions
- Stock Market
- Equities
- CYTK Stock
- Consensus Cytokinetics, Incorporated